Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ocular Oncology
•
Ophthalmology
•
Vitreoretinal Diseases and Surgery
What factors influence the decision to initiate anti-VEGF injections to prevent radiation retinopathy after plaque brachytherapy?
Related Questions
Do you utilize thrombolytic therapy in patients with CRAO?
How do you approach the management of a patient with a small, indeterminate choroidal mass with no obvious primary malignancy?
When should delayed removal of an intraocular foreign body be considered?
How do you manage macular-threatening toxoplasma chorioretinitis in pregnancy?
What is your approach for LINAC based radiosurgery when dealing with benign perioptic lesions very close to the optics apparatus?
How do you decide on treatment modality for ocular surface squamous neoplasia?
What factors guide the decision to treat with ROP laser treatment versus a repeat anti-VEGF injection in a child who has previously received anti-VEGF therapy for retinopathy of prematurity (ROP)?
How do you manage a situation where the lens optic shifts in front of the iris after a Yamane technique?
When should methotrexate injections be initiated for proliferative vitreoretinopathy?
What is your approach to antiviral treatment of HSV acute retinal necrosis?